TY - JOUR
T1 - Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence
AU - ORBEX, a multicenter clinical trial network funded by the National Heart, Lung, and Blood Institute
AU - Devonshire, Ashley L.
AU - Guilbert, Theresa
AU - Bauer, Cindy S.
AU - Schmidt, Heidi
AU - Davis, Stephanie
AU - Hernandez, Michelle
AU - Fitzpatrick, Anne M.
AU - Gaffin, Jonathan M.
AU - Kattan, Meyer
AU - De, Aliva
AU - Jackson, Daniel J.
AU - Mauger, David
AU - Phipatanakul, Wanda
AU - Schwartz, Justin T.
AU - Sheehan, William
AU - Long, Dayna
AU - Juarez, Lourdes
AU - Bacharier, Leonard B.
AU - Stokes, Jeffrey R.
AU - Teach, Stephen J.
AU - Morgan, Wayne J.
AU - Martinez, Fernando D.
N1 - Publisher Copyright:
© 2025 American Academy of Allergy, Asthma & Immunology
PY - 2025/8
Y1 - 2025/8
N2 - Multiple early life environmental exposures are thought to influence childhood asthma incidence. The coronavirus disease 2019 (COVID-19) pandemic resulted in changes in air pollution levels and a marked disruption in the circulation of childhood respiratory viruses. Both air pollution and respiratory viruses have been implicated in the development of asthma and early childhood wheeze. Human behavior and daily routine practices, including family gatherings and daycare attendance, were impacted profoundly by the COVID-19 pandemic and the associated mitigation measures. The changes to human behavior and social interactions that occurred during the pandemic have and will likely continue to impact chronic diseases, including the development of asthma. This rostrum explores how childhood asthma incidence might be affected by the COVID-19 pandemic and its associated public health mitigation measures. Recently completed and ongoing clinical trials being conducted in the infant and toddler population and assessing allergic outcomes may be well positioned to examine the impact of the pandemic on asthma incidence and time to asthma onset.
AB - Multiple early life environmental exposures are thought to influence childhood asthma incidence. The coronavirus disease 2019 (COVID-19) pandemic resulted in changes in air pollution levels and a marked disruption in the circulation of childhood respiratory viruses. Both air pollution and respiratory viruses have been implicated in the development of asthma and early childhood wheeze. Human behavior and daily routine practices, including family gatherings and daycare attendance, were impacted profoundly by the COVID-19 pandemic and the associated mitigation measures. The changes to human behavior and social interactions that occurred during the pandemic have and will likely continue to impact chronic diseases, including the development of asthma. This rostrum explores how childhood asthma incidence might be affected by the COVID-19 pandemic and its associated public health mitigation measures. Recently completed and ongoing clinical trials being conducted in the infant and toddler population and assessing allergic outcomes may be well positioned to examine the impact of the pandemic on asthma incidence and time to asthma onset.
UR - https://www.scopus.com/pages/publications/105009926470
UR - https://www.scopus.com/inward/citedby.url?scp=105009926470&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2025.04.056
DO - 10.1016/j.jaip.2025.04.056
M3 - Article
C2 - 40379243
AN - SCOPUS:105009926470
SN - 2213-2198
VL - 13
SP - 1952
EP - 1959
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 8
ER -
